R. Michael Carruthers
2017 - Nivalis Therapeutics
In 2017, R. Michael Carruthers earned a total compensation of $905.7K as Former Interim President and Chief Financial Officer at Nivalis Therapeutics, a 16% decrease compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Option Awards | $174,600 |
| Salary | $201,613 |
| Other | $429,456 |
| Total | $905,669 |
Carruthers received $429.5K in other compensation, accounting for 47% of the total pay in 2017.
Carruthers also received $100K in bonus, $174.6K in option awards and $201.6K in salary.
Rankings
In 2017, R. Michael Carruthers' compensation ranked 9,452nd out of 14,666 executives tracked by ExecPay. In other words, Carruthers earned more than 35.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,452 out of 14,666 | 36th |
Division Manufacturing | 3,635 out of 5,772 | 37th |
Major group Chemicals And Allied Products | 1,255 out of 2,075 | 40th |
Industry group Drugs | 1,009 out of 1,731 | 42nd |
Industry Pharmaceutical Preparations | 792 out of 1,333 | 41st |
Source: SEC filing on April 24, 2018.
Carruthers' colleagues
We found five more compensation records of executives who worked with R. Michael Carruthers at Nivalis Therapeutics in 2017.
2017
Mitchell Gold
Nivalis Therapeutics
Chief Executive Officer
2017
Janice Troha
Nivalis Therapeutics
Chief Operating Officer
2017
Jon Congleton
Nivalis Therapeutics
Chief Executive Officer
2017
Stanford Peng
Nivalis Therapeutics
Chief Medical Officer
2017
Paul Rickey
Nivalis Therapeutics